Novel Tetrahydropyridinyl-6,6-BicyclicCompounds as 5-HT2A ReceptorAgonists for Treating Depression,Anxiety, Substance Abuse, and Headaches
Abstract Provided herein are novel tetrahydropyridinyl-6,6-bicyclic compounds as 5-HT2A receptor agonists, pharmaceutical compositions, use of such compounds in treating depression, anxiety, substance abuse and headaches, and processes for preparing such compounds.
Authors
- Ram W. Sabnis (ORCID: https://orcid.org/0000-0001-7289-0581)
- Anika R. Sabnis
Institutions
- Mayo Clinic (US)
Publication Details
- Journal
- ACS Medicinal Chemistry Letters
- Published
- 2026-08-13
- DOI
- https://doi.org/10.1021/acsmedchemlett.6c00430
- Primary Topic
- Chemical synthesis and alkaloids
- Type
- article
- Field-Weighted Citation Impact
- 0.00